Fungal Infections

Total Page:16

File Type:pdf, Size:1020Kb

Fungal Infections 10 Fungal Infections Abida K. Haque and Michael R. McGinnis The incidence of invasive fungal infections has increased Thus, fungi can elicit similar tissue reactions as bacteria, dramatically over the past two decades, mostly due to including acute exudative, necrotizing, and granulomatous an increase in the number of immunocompromised reactions. Pathogenicity of fungi depends on the virulence l patients. -4 Patients who undergo chemotherapy for a of the particular fungus, the infecting dose, the route of variety of diseases, patients with organ transplants, and infection, and the immune status of the host. Other factors patients with the acquired immune deficiency syndrome that influence the pathogenicity include the coexistence have contributed most to the increase in fungal infec­ of other infections in the host, the organs affected, and tions.s The actual incidence of invasive fungal infections other underlying diseases. There is no clear-cut evidence in transplant patients ranges from 15% to 25% in bone that fungal infections are contagious, with the exception marrow transplant recipients to 5% to 42% in solid organ of dermatophytoses, pityriasis versicolor, and candidiasis 6 transplant recipients. ,7 The most frequently encountered of the newborn. However, accidental inoculation or direct are Aspergillus species, followed by Cryptococcus and contamination of an open wound can result in transmis­ Candida species. Fungal infections are also associated sion of the etiologic agent of infection.13 Hence care with a higher mortality than either bacterial or viral infec­ should be taken to avoid direct contact when handling tions in these patient popUlations. This is because of the contaminated bodily discharges and tissues. limited number of available therapies, dose-limiting tox­ Most pulmonary infections begin in the lungs following 12 icities of the antifungal drugs, fewer symptoms due to inhalation of aerosolized fungi from the environment. ,14 lack of inflammatory response, and the lack of sensitive Once the fungi reach the lungs, the infection can remain tests to aid in the diagnosis of invasive fungal infections. I localized, or it can disseminate to produce severe sys­ A study of patients with fungal infections admitted to a temic disease that is often fatal. Rarely, the gastrointesti­ university-affiliated hospital indicated that community­ nal tract and skin may be the primary focus of systemic acquired infections are becoming a serious problem; 67% infection with secondary involvement of the lungs, espe­ of the 140 patients had community-acquired fungal pneu­ cially in immunocompromised patients. monia.8 There is also an increase in nosocomial fungal The discussion of fungi in this chapter is confined to infections.9 invasive pulmonary infections. Fungi that cause invasive Fungi are eukaryotic, unicellular to multicellular organ­ pulmonary infection can be divided in two main groups: isms that have chitinous cell walls, and reproduce asexu­ (1) primary or true pathogens, and (2) opportunistic ally, sexually, or both ways. Fungal cells are larger and pathogens. The primary or true pathogenic fungi (also genomically more complex than bacteria. Their cell wall referred to as endemic fungi) infect healthy, immunologi­ 15 contains polysaccharides, proteins, and sugars, and their cally competent individuals. ,16 These fungi can be very antigens are rich in complex polysaccharides and glyco­ aggressive, and produce severe disseminated and fatal proteins. Plasma membranes of fungi contain ergosterol, infections in immunocompromised patients. While which is the primary target for antifungals such as ampho­ endemic fungi such as Histoplasma capsulatum and Coc­ tericin B. Although there are more than 1.3 million fungal cidioides immitis are the most common, a number of species in the environment, only about 150 are known to other fungi have emerged as important, though less be pathogenic to humans. For detailed taxonomy of the common pathogens. Penicillium marneffei, Fusarium fungi, several texts are available. W-12 The virulence factors species, Scedosporium species, and Malassezia species are of fungi resemble those of bacteria, such as possession of increasing in incidence as opportunistic infections in a capsule, adhesion molecules, toxins, free radicals, etc. immunocompromised hosts, especially in those with 349 350 A.K. Haque and M,R. McGinnis 17 8 AIDS. ,1 Each of these fungi can cause systemic life (3) molecular diagnostic techniques. A combination of threatening infections. In contrast, the opportunistic fungi these approaches is recommended, but is not always cause infections in critically ill or immunosuppressed possible.25 patients. Almost all opportunistic fungi gain entry through the lungs, except endogenous Candida spp. The most Isolation of Fungi by Culture common opportunistic mycoses include candidiasis, aspergillosis, cryptococcosis, zygomycosis, pseudallesche­ Most of the fungi that cause invasive infection can be riasis, fusariosis, and trichosporonosis. cultured on standard laboratory media. One of the major The dramatic increase in opportunistic fungal infection advancements over the past two decades has been in the in the latter half of the 20th century is related to several culture and recovery of fungi from blood.1.26 Biphasic 17 factors. .l9.20 The important factors include immunosup­ systems were the first advancement in the broth-based pression of transplant patients, chemotherapy for malig­ culture system, This was followed by the development of nancies, broad-spectrum therapy for bacterial infections, lysis centrifugation, involving the incorporation of a tube and the long-term placements of catheters for various containing an anticoagulant and a lytic agent, centrifuga­ therapies. Other conditions that predispose to opportu­ tion, and placement of the pellet on solid media. Although nistic infections include malignancies, especially leuke­ labor intensive and relatively expensive, this method has mia and lymphomas, chronic lung diseases, abdominal become the "gold standard" for recovery of fungi from surgery, burns, diabetes mellitus, Cushing's syndrome, blood.27.28 Automated blood culture systems have been malnutrition, uremia, alcohol abuse with cirrhosis, drug developed, that are superior in their recovery of yeast abuse, congenital immunodeficiency syndromes, and from blood.29 Despite these advances in technology, isola­ AIDS.5,18.21 Epidemiologic factors such as an increasing tion of fungi from blood cultures is an insensitive marker aging population and migration of susceptible persons for invasive fungal infections, and often takes several into highly endemic areas also contribute to the increase days to weeks for growth, resulting in delays in treatment. in opportunistic infections,22 Fungemia was found in only 28% of patients with autopsy­ Host factors responsible for increased susceptibility to proven invasive candidiasis in one series, and only 58% fungal infections include (1) a decrease in the number or of patients with two or more visceral infections had functional impairment of mature granulocytes and mono­ fungemia. 30 Most of the fungi that cause invasive pulmo­ nuclearphagocytes, (2) depressed B-Iymphocyte (humoral) nary infections can be cultured on standard media; immunity resulting in decreased production of immuno­ however, culture and characterization may take up to 2 globulins and impaired opsonization, (3) depressed T­ to 4 weeks. lymphocyte (cell-mediated) immunity, (4) abnormal host When a fungus is isolated, the question may still remain immune-regulation,20.23.24 and (5) neutropenia. Other whether the isolate is an invasive pathogen, normal flora factors include disruption of mucosal and skin barriers, not causing infection, or an environmental contaminant. disorders of complement system, and hereditary immune Often the specimen may not be sent to the laboratory dysfunctions.23.24 for culture and entirely submitted for histologic evalua­ Fungal infections in severely immunocompromised tion. Pathologists therefore have to rely on their ability patients present with clinical features that are often dif­ to recognize and identify fungi in smears and tissue sec­ ferent from immunocompetent patients. The tissue tions. The presence of a fungus growing in tissue provides response is also different. There may be little or no inflam­ indisputable evidence of invasive infection. Histologic matory response with even massive infection, and there studies can also confirm the presence of other concomi­ may not be granuloma formation. Additionally, coexist­ tant infections by bacteria, viruses, protozoa, and para­ ing infections are very common; therefore, the possibility sites. Finally, no other diagnostic test can determine of multiple infectious agents should never be overlooked. whether the host response signifies invasion or allergic Special stains or immunostains for fungi and other organ­ reaction. Although certain patterns of host reaction isms should be routinely used for demonstrating fungi suggest that mycosis exists, there are no absolute criteria and other infectious agents in severely immunocompro­ that permit an etiologic diagnosis with as much certainty mised patients. as tissue diagnosis. Currently Available Histologic Diagnosis of Fungal Infections Diagnostic Methods Although different methods of diagnosis are available for fungal infections, the presence of a fungus in the tissue Currently available laboratory methods for diagnosing sections provides indisputable
Recommended publications
  • Next-Generation Sequencing for Hypothesis-Free Genomic Detection
    Frickmann et al. BMC Microbiology (2019) 19:75 https://doi.org/10.1186/s12866-019-1448-0 RESEARCH ARTICLE Open Access Next-generation sequencing for hypothesis- free genomic detection of invasive tropical infections in poly-microbially contaminated, formalin-fixed, paraffin-embedded tissue samples – a proof-of-principle assessment Hagen Frickmann1,2* , Carsten Künne3, Ralf Matthias Hagen4, Andreas Podbielski2, Jana Normann2, Sven Poppert5,6, Mario Looso3 and Bernd Kreikemeyer2 Abstract Background: The potential of next-generation sequencing (NGS) for hypothesis-free pathogen diagnosis from (poly-)microbially contaminated, formalin-fixed, paraffin embedded tissue samples from patients with invasive fungal infections and amebiasis was investigated. Samples from patients with chromoblastomycosis (n = 3), coccidioidomycosis (n = 2), histoplasmosis (n = 4), histoplasmosis or cryptococcosis with poor histological discriminability (n = 1), mucormycosis (n = 2), mycetoma (n = 3), rhinosporidiosis (n = 2), and invasive Entamoeba histolytica infections (n = 6) were analyzed by NGS (each one Illumina v3 run per sample). To discriminate contamination from putative infections in NGS analysis, mean and standard deviation of the number of specific sequence fragments (paired reads) were determined and compared in all samples examined for the pathogens in question. Results: For matches between NGS results and histological diagnoses, a percentage of species-specific reads greater than the 4th standard deviation above the mean value of all 23 assessed sample materials was required. Potentially etiologically relevant pathogens could be identified by NGS in 5 out of 17 samples of patients with invasive mycoses and in 1 out of 6 samples of patients with amebiasis. Conclusions: The use of NGS for hypothesis-free pathogen diagnosis from contamination-prone formalin- fixed, paraffin-embedded tissue requires further standardization.
    [Show full text]
  • Congo DRC, Kamwiziku. Mycoses 2021
    Received: 8 April 2021 | Revised: 1 June 2021 | Accepted: 10 June 2021 DOI: 10.1111/myc.13339 REVIEW ARTICLE Serious fungal diseases in Democratic Republic of Congo – Incidence and prevalence estimates Guyguy K. Kamwiziku1 | Jean- Claude C. Makangara1 | Emma Orefuwa2 | David W. Denning2,3 1Department of Microbiology, Kinshasa University Hospital, University of Abstract Kinshasa, Kinshasa, Democratic Republic A literature review was conducted to assess the burden of serious fungal infections of Congo 2Global Action Fund for Fungal Infections, in the Democratic Republic of the Congo (DRC) (population 95,326,000). English and Geneva, Switzerland French publications were listed and analysed using PubMed/Medline, Google Scholar 3 Manchester Fungal Infection Group, The and the African Journals database. Publication dates spanning 1943– 2020 were in- University of Manchester, Manchester Academic Health Science Centre, cluded in the scope of the review. From the analysis of published articles, we estimate Manchester, UK a total of about 5,177,000 people (5.4%) suffer from serious fungal infections in the Correspondence DRC annually. The incidence of cryptococcal meningitis, Pneumocystis jirovecii pneu- Guyguy K. Kamwiziku, Department monia in adults and invasive aspergillosis in AIDS patients was estimated at 6168, of Microbiology, Kinshasa University Hospital, University of Kinshasa, Congo. 2800 and 380 cases per year. Oral and oesophageal candidiasis represent 50,470 Email: [email protected] and 28,800 HIV- infected patients respectively. Chronic pulmonary aspergillosis post- tuberculosis incidence and prevalence was estimated to be 54,700. Fungal asthma (allergic bronchopulmonary aspergillosis and severe asthma with fungal sensitiza- tion) probably has a prevalence of 88,800 and 117,200.
    [Show full text]
  • Candida Krusei: Biology, Epidemiology, Pathogenicity and Clinical Manifestations of an Emerging Pathogen
    J. Med. Microbiol. - Vol. 41 (1994), 295-310 0 1994 The Pathological Society of Great Britain and Ireland REVIEW ARTICLE: CLINICAL MYCOLOGY Candida krusei: biology, epidemiology, pathogenicity and clinical manifestations of an emerging pathogen YUTHIKA H. SAMARANAYAKE and L. P. SAMARANAYAKE” Department of Pathology (Oral), Faculty of Medicine and Ord diology Unit, Faculty of Dentistry, University of Hong Kong, 34 Hospital Road, Hong Kong Summary. Early reports of Candida krusei in man describe the organism as a transient, infrequent isolate of minor clinical significance inhabiting the mucosal surfaces. More recently it has emerged as a notable pathogen with a spectrum of clinical manifestations such as fungaemia, endophthalmitis, arthritis and endocarditis, most of which usually occur in compromised patient groups in a nosocomial setting. The advent of human immunodeficiency virus infection and the widespread use of the newer triazole fluconazole to suppress fungal infections in these patients have contributed to a significant increase in C. krusei infection, particularly because of the high incidence of resistance of the yeast to this drug. Experimental studies have generally shown C. krusei to be less virulent than C. albicans in terms of its adherence to both epithelial and prosthetic surfaces, proteolytic potential and production of phospholipases. Furthermore, it would seem that C. krusei is significantlydifferent from other medically important Candida spp. in its structural and metabolic features, and exhibits different behaviour patterns towards host defences, adding credence to the belief that it should be re-assigned taxonomically. An increased awareness of the pathogenic potential of this yeast coupled with the newer molecular biological approaches to its study may facilitate the continued exploration of the epidemiology and pathogenesis of C.
    [Show full text]
  • Reproduction in Plants Which But, She Has Never Seen the Seeds We Shall Learn in This Chapter
    Reproduction in 12 Plants o produce its kind is a reproduction, new plants are obtained characteristic of all living from seeds. Torganisms. You have already learnt this in Class VI. The production of new individuals from their parents is known as reproduction. But, how do Paheli thought that new plants reproduce? There are different plants always grow from seeds. modes of reproduction in plants which But, she has never seen the seeds we shall learn in this chapter. of sugarcane, potato and rose. She wants to know how these plants 12.1 MODES OF REPRODUCTION reproduce. In Class VI you learnt about different parts of a flowering plant. Try to list the various parts of a plant and write the Asexual reproduction functions of each. Most plants have In asexual reproduction new plants are roots, stems and leaves. These are called obtained without production of seeds. the vegetative parts of a plant. After a certain period of growth, most plants Vegetative propagation bear flowers. You may have seen the It is a type of asexual reproduction in mango trees flowering in spring. It is which new plants are produced from these flowers that give rise to juicy roots, stems, leaves and buds. Since mango fruit we enjoy in summer. We eat reproduction is through the vegetative the fruits and usually discard the seeds. parts of the plant, it is known as Seeds germinate and form new plants. vegetative propagation. So, what is the function of flowers in plants? Flowers perform the function of Activity 12.1 reproduction in plants. Flowers are the Cut a branch of rose or champa with a reproductive parts.
    [Show full text]
  • Fungal Infections from Human and Animal Contact
    Journal of Patient-Centered Research and Reviews Volume 4 Issue 2 Article 4 4-25-2017 Fungal Infections From Human and Animal Contact Dennis J. Baumgardner Follow this and additional works at: https://aurora.org/jpcrr Part of the Bacterial Infections and Mycoses Commons, Infectious Disease Commons, and the Skin and Connective Tissue Diseases Commons Recommended Citation Baumgardner DJ. Fungal infections from human and animal contact. J Patient Cent Res Rev. 2017;4:78-89. doi: 10.17294/2330-0698.1418 Published quarterly by Midwest-based health system Advocate Aurora Health and indexed in PubMed Central, the Journal of Patient-Centered Research and Reviews (JPCRR) is an open access, peer-reviewed medical journal focused on disseminating scholarly works devoted to improving patient-centered care practices, health outcomes, and the patient experience. REVIEW Fungal Infections From Human and Animal Contact Dennis J. Baumgardner, MD Aurora University of Wisconsin Medical Group, Aurora Health Care, Milwaukee, WI; Department of Family Medicine and Community Health, University of Wisconsin School of Medicine and Public Health, Madison, WI; Center for Urban Population Health, Milwaukee, WI Abstract Fungal infections in humans resulting from human or animal contact are relatively uncommon, but they include a significant proportion of dermatophyte infections. Some of the most commonly encountered diseases of the integument are dermatomycoses. Human or animal contact may be the source of all types of tinea infections, occasional candidal infections, and some other types of superficial or deep fungal infections. This narrative review focuses on the epidemiology, clinical features, diagnosis and treatment of anthropophilic dermatophyte infections primarily found in North America.
    [Show full text]
  • Feeding-Dependent Tentacle Development in the Sea Anemone Nematostella Vectensis
    bioRxiv preprint doi: https://doi.org/10.1101/2020.03.12.985168; this version posted March 12, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. Feeding-dependent tentacle development in the sea anemone Nematostella vectensis Aissam Ikmi1,2*, Petrus J. Steenbergen1, Marie Anzo1, Mason R. McMullen2,3, Anniek Stokkermans1, Lacey R. Ellington2, and Matthew C. Gibson2,4 Affiliations: 1Developmental Biology Unit, European Molecular Biology Laboratory, 69117 Heidelberg, Germany. 2Stowers Institute for Medical Research, Kansas City, Missouri 64110, USA. 3Department of Pharmacy, The University of Kansas Health System, Kansas City, Kansas 66160, USA. 4Department of Anatomy and Cell Biology, The University of Kansas School of Medicine, Kansas City, Kansas 66160, USA. *Corresponding author. Email: [email protected] 1 bioRxiv preprint doi: https://doi.org/10.1101/2020.03.12.985168; this version posted March 12, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. Summary In cnidarians, axial patterning is not restricted to embryonic development but continues throughout a prolonged life history filled with unpredictable environmental changes. How this developmental capacity copes with fluctuations of food availability and whether it recapitulates embryonic mechanisms remain poorly understood. To address these questions, we utilize the tentacles of the sea anemone Nematostella vectensis as a novel paradigm for developmental patterning across distinct life history stages.
    [Show full text]
  • A Case of Disseminated Histoplasmosis Detected in Peripheral Blood Smear Staining Revealing AIDS at Terminal Phase in a Female Patient from Cameroon
    Hindawi Publishing Corporation Case Reports in Medicine Volume 2012, Article ID 215207, 3 pages doi:10.1155/2012/215207 Case Report A Case of Disseminated Histoplasmosis Detected in Peripheral Blood Smear Staining Revealing AIDS at Terminal Phase in a Female Patient from Cameroon Christine Mandengue Ebenye Cliniques Universitaires des Montagnes, Bangangt´e, Cameroon Correspondence should be addressed to Christine Mandengue Ebenye, [email protected] Received 28 August 2012; Revised 2 November 2012; Accepted 5 November 2012 Academic Editor: Ingo W. Husstedt Copyright © 2012 Christine Mandengue Ebenye. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Histoplasmosis is endemic in the American continent and also in Sub-Saharan Africa, coexisting with the African histoplasmosis. Immunosuppressed patients, especially those with advanced HIV infection develop a severe disseminated histoplasmosis with fatal prognosis. The definitive diagnosis of disseminated histoplasmosis is based on the detection of Histoplasma capsulatum from patient’ tissues samples or body fluids. Among the diagnostic tests peripheral blood smear staining is not commonly used. Nonetheless a few publications reveal that Histoplasma capsulatum has been discovered by chance using this method in HIV infected patients with chronic fever and hence revealed AIDS at the terminal phase. We report a new case detected in a Cameroonian woman without any previous history of HIV infection. Peripheral blood smear staining should be commonly used for the diagnosis of disseminated histoplasmosis in the Sub-Saharan Africa, where facilities for mycology laboratories are unavailable. 1. Introduction 1987 [2].
    [Show full text]
  • Epidemiology and Geographic Distribution of Blastomycosis, Histoplasmosis, and Coccidioidomycosis, Ontario, Canada, 1990–2015 Elizabeth M
    Epidemiology and Geographic Distribution of Blastomycosis, Histoplasmosis, and Coccidioidomycosis, Ontario, Canada, 1990–2015 Elizabeth M. Brown,1 Lisa R. McTaggart,1 Deirdre Dunn, Elizabeth Pszczolko, Kar George Tsui, Shaun K. Morris, Derek Stephens, Julianne V. Kus,2 Susan E. Richardson2 In support of improving patient care, this activity has been planned and implemented by Medscape, LLC and Emerging Infectious Diseases. Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Medscape, LLC designates this Journal-based CME activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. All other clinicians completing this activity will be issued a certificate of participation. To participate in this journal CME activity: (1) review the learning objectives and author disclosures; (2) study the education content; (3) take the post-test with a 75% minimum passing score and complete the evaluation at http://www.medscape.org/journal/eid; and (4) view/print certificate. For CME questions, see page 1400. Release date: June 15, 2018; Expiration date: June 15, 2019 Learning Objectives Upon completion of this activity, participants will be able to: • Describe the epidemiology and geographic distribution of microbiology laboratory-confirmed
    [Show full text]
  • Fungi in Bronchiectasis: a Concise Review
    International Journal of Molecular Sciences Review Fungi in Bronchiectasis: A Concise Review Luis Máiz 1, Rosa Nieto 1 ID , Rafael Cantón 2 ID , Elia Gómez G. de la Pedrosa 2 and Miguel Ángel Martinez-García 3,* ID 1 Servicio de Neumología, Unidad de Bronquiectasias y Fibrosis Quística, Hospital Universitario Ramón y Cajal, 28034 Madrid, Spain; [email protected] (L.M.); [email protected] (R.N.) 2 Servicio de Microbiología, Hospital Universitario Ramón y Cajal and Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), 28034 Madrid, Spain; [email protected] (R.C.); [email protected] (E.G.G.d.l.P.) 3 Servicio de Neumología, Hospital Universitario y Politécnico la Fe, 46016 Valencia, Spain * Correspondence: [email protected]; Tel.: +34-60-986-5934 Received: 3 December 2017; Accepted: 31 December 2017; Published: 4 January 2018 Abstract: Although the spectrum of fungal pathology has been studied extensively in immunosuppressed patients, little is known about the epidemiology, risk factors, and management of fungal infections in chronic pulmonary diseases like bronchiectasis. In bronchiectasis patients, deteriorated mucociliary clearance—generally due to prior colonization by bacterial pathogens—and thick mucosity propitiate, the persistence of fungal spores in the respiratory tract. The most prevalent fungi in these patients are Candida albicans and Aspergillus fumigatus; these are almost always isolated with bacterial pathogens like Haemophillus influenzae and Pseudomonas aeruginosa, making very difficult to define their clinical significance. Analysis of the mycobiome enables us to detect a greater diversity of microorganisms than with conventional cultures. The results have shown a reduced fungal diversity in most chronic respiratory diseases, and that this finding correlates with poorer lung function.
    [Show full text]
  • Fungal Infection in the Lung
    CHAPTER Fungal Infection in the Lung 52 Udas Chandra Ghosh, Kaushik Hazra INTRODUCTION The following risk factors may predispose to develop Pneumonia is the leading infectious cause of death in fungal infections in the lungs 6 1, 2 developed countries . Though the fungal cause of 1. Acute leukemia or lymphoma during myeloablative pneumonia occupies a minor portion in the immune- chemotherapy competent patients, but it causes a major role in immune- deficient populations. 2. Bone marrow or peripheral blood stem cell transplantation Fungi may colonize body sites without producing disease or they may be a true pathogen, generating a broad variety 3. Solid organ transplantation on immunosuppressive of clinical syndromes. treatment Fungal infections of the lung are less common than 4. Prolonged corticosteroid therapy bacterial and viral infections and very difficult for 5. Acquired immunodeficiency syndrome diagnosis and treatment purposes. Their virulence varies from causing no symptoms to death. Out of more than 1 6. Prolonged neutropenia from various causes lakh species only few fungi cause human infection and 7. Congenital immune deficiency syndromes the most vulnerable organs are skin and lungs3, 4. 8. Postsplenectomy state RISK FACTORS 9. Genetic predisposition Workers or farmers with heavy exposure to bird, bat, or rodent droppings or other animal excreta in endemic EPIDEMIOLOGY OF FUNGAL PNEUMONIA areas are predisposed to any of the endemic fungal The incidences of invasive fungal infections have pneumonias, such as histoplasmosis, in which the increased during recent decades, largely because of the environmental exposure to avian or bat feces encourages increasing size of the population at risk. This population the growth of the organism.
    [Show full text]
  • Severe Chromoblastomycosis-Like Cutaneous Infection Caused by Chrysosporium Keratinophilum
    fmicb-08-00083 January 25, 2017 Time: 11:0 # 1 CASE REPORT published: 25 January 2017 doi: 10.3389/fmicb.2017.00083 Severe Chromoblastomycosis-Like Cutaneous Infection Caused by Chrysosporium keratinophilum Juhaer Mijiti1†, Bo Pan2,3†, Sybren de Hoog4, Yoshikazu Horie5, Tetsuhiro Matsuzawa6, Yilixiati Yilifan1, Yong Liu1, Parida Abliz7, Weihua Pan2,3, Danqi Deng8, Yun Guo8, Peiliang Zhang8, Wanqing Liao2,3* and Shuwen Deng2,3,7* 1 Department of Dermatology, People’s Hospital of Xinjiang Uygur Autonomous Region, Urumqi, China, 2 Department of Dermatology, Shanghai Changzheng Hospital, Second Military Medical University, Shanghai, China, 3 Key Laboratory of Molecular Medical Mycology, Shanghai Changzheng Hospital, Second Military Medical University, Shanghai, China, 4 CBS-KNAW Fungal Biodiversity Centre, Royal Netherlands Academy of Arts and Sciences, Utrecht, Netherlands, 5 Medical Mycology Research Center, Chiba University, Chiba, Japan, 6 Department of Nutrition Science, University of Nagasaki, Nagasaki, Japan, 7 Department of Dermatology, First Hospital of Xinjiang Medical University, Urumqi, China, 8 Department of Dermatology, The Second Affiliated Hospital of Kunming Medical University, Kunming, China Chrysosporium species are saprophytic filamentous fungi commonly found in the Edited by: soil, dung, and animal fur. Subcutaneous infection caused by this organism is Leonard Peruski, rare in humans. We report a case of subcutaneous fungal infection caused by US Centers for Disease Control and Prevention, USA Chrysosporium keratinophilum in a 38-year-old woman. The patient presented with Reviewed by: severe chromoblastomycosis-like lesions on the left side of the jaw and neck for 6 years. Nasib Singh, She also got tinea corporis on her trunk since she was 10 years old.
    [Show full text]
  • Managing Athlete's Foot
    South African Family Practice 2018; 60(5):37-41 S Afr Fam Pract Open Access article distributed under the terms of the ISSN 2078-6190 EISSN 2078-6204 Creative Commons License [CC BY-NC-ND 4.0] © 2018 The Author(s) http://creativecommons.org/licenses/by-nc-nd/4.0 REVIEW Managing athlete’s foot Nkatoko Freddy Makola,1 Nicholus Malesela Magongwa,1 Boikgantsho Matsaung,1 Gustav Schellack,2 Natalie Schellack3 1 Academic interns, School of Pharmacy, Sefako Makgatho Health Sciences University 2 Clinical research professional, pharmaceutical industry 3 Professor, School of Pharmacy, Sefako Makgatho Health Sciences University *Corresponding author, email: [email protected] Abstract This article is aimed at providing a succinct overview of the condition tinea pedis, commonly referred to as athlete’s foot. Tinea pedis is a very common fungal infection that affects a significantly large number of people globally. The presentation of tinea pedis can vary based on the different clinical forms of the condition. The symptoms of tinea pedis may range from asymptomatic, to mild- to-severe forms of pain, itchiness, difficulty walking and other debilitating symptoms. There is a range of precautionary measures available to prevent infection, and both oral and topical drugs can be used for treating tinea pedis. This article briefly highlights what athlete’s foot is, the different causes and how they present, the prevalence of the condition, the variety of diagnostic methods available, and the pharmacological and non-pharmacological management of the
    [Show full text]